BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29251790)

  • 41. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
    Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
    Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Specific and redundant activities of ETV1 and ETV4 in prostate cancer aggressiveness revealed by co-overexpression cellular contexts.
    Mesquita D; Barros-Silva JD; Santos J; Skotheim RI; Lothe RA; Paulo P; Teixeira MR
    Oncotarget; 2015 Mar; 6(7):5217-36. PubMed ID: 25595908
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PTPN11/Shp2 overexpression enhances liver cancer progression and predicts poor prognosis of patients.
    Han T; Xiang DM; Sun W; Liu N; Sun HL; Wen W; Shen WF; Wang RY; Chen C; Wang X; Cheng Z; Li HY; Wu MC; Cong WM; Feng GS; Ding J; Wang HY
    J Hepatol; 2015 Sep; 63(3):651-60. PubMed ID: 25865556
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatocyte growth factor upregulates E1AF that induces oral squamous cell carcinoma cell invasion by activating matrix metalloproteinase genes.
    Hanzawa M; Shindoh M; Higashino F; Yasuda M; Inoue N; Hida K; Ono M; Kohgo T; Nakamura M; Notani K; Fukuda H; Totsuka Y; Yoshida K; Fujinaga K
    Carcinogenesis; 2000 Jun; 21(6):1079-85. PubMed ID: 10836994
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Capicua tumor suppressor: a gatekeeper of Ras signaling in development and cancer.
    Simón-Carrasco L; Jiménez G; Barbacid M; Drosten M
    Cell Cycle; 2018; 17(6):702-711. PubMed ID: 29578365
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
    Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
    Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A novel KLF6-Rho GTPase axis regulates hepatocellular carcinoma cell migration and dissemination.
    Ahronian LG; Zhu LJ; Chen YW; Chu HC; Klimstra DS; Lewis BC
    Oncogene; 2016 Sep; 35(35):4653-62. PubMed ID: 26876204
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
    Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
    [TBL] [Abstract][Full Text] [Related]  

  • 50. From cirrhosis to hepatocellular carcinoma in HCV-infected patients: genes involved in tumor progression.
    Wang Y; Li J; Chen J; Liu L; Peng Z; Ding J; Ding K
    Eur Rev Med Pharmacol Sci; 2012 Aug; 16(8):995-1000. PubMed ID: 22913147
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transforming growth factor β-interacting factor-induced malignant progression of hepatocellular carcinoma cells depends on superoxide production from Nox4.
    Liu ZM; Tseng HY; Tsai HW; Su FC; Huang HS
    Free Radic Biol Med; 2015 Jul; 84():54-64. PubMed ID: 25841779
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma.
    Fang F; Chang RM; Yu L; Lei X; Xiao S; Yang H; Yang LY
    J Hepatol; 2015 Oct; 63(4):874-85. PubMed ID: 25998163
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL; Wang WY; Yao WQ; Li GD
    Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
    Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
    J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MicroRNA-424 inhibits Akt3/E2F3 axis and tumor growth in hepatocellular carcinoma.
    Yang H; Zheng W; Shuai X; Chang RM; Yu L; Fang F; Yang LY
    Oncotarget; 2015 Sep; 6(29):27736-50. PubMed ID: 26315541
    [TBL] [Abstract][Full Text] [Related]  

  • 56. NANOG gene expression is regulated by the ETS transcription factor ETV4 in human embryonic carcinoma NCCIT cells.
    Park SW; Do HJ; Choi W; Song H; Chung HJ; Kim JH
    Biochem Biophys Res Commun; 2017 Jun; 487(3):532-538. PubMed ID: 28412366
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sorafenib down-regulates expression of HTATIP2 to promote invasiveness and metastasis of orthotopic hepatocellular carcinoma tumors in mice.
    Zhang W; Sun HC; Wang WQ; Zhang QB; Zhuang PY; Xiong YQ; Zhu XD; Xu HX; Kong LQ; Wu WZ; Wang L; Song TQ; Li Q; Tang ZY
    Gastroenterology; 2012 Dec; 143(6):1641-1649.e5. PubMed ID: 22922424
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Heterogeneity of hepatocellular carcinoma contributes to cancer progression.
    Jeng KS; Chang CF; Jeng WJ; Sheen IS; Jeng CJ
    Crit Rev Oncol Hematol; 2015 Jun; 94(3):337-47. PubMed ID: 25680939
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MicroRNA-150 suppresses cell proliferation and metastasis in hepatocellular carcinoma by inhibiting the GAB1-ERK axis.
    Sun W; Zhang Z; Wang J; Shang R; Zhou L; Wang X; Duan J; Ruan B; Gao Y; Dai B; Qu S; Liu W; Ding R; Wang L; Wang D; Dou K
    Oncotarget; 2016 Mar; 7(10):11595-608. PubMed ID: 26871477
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblasts.
    Mazzocca A; Dituri F; Lupo L; Quaranta M; Antonaci S; Giannelli G
    Hepatology; 2011 Sep; 54(3):920-30. PubMed ID: 21674557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.